CompletedNot Applicable

ALLiance for sEcondary PREvention After an Episode of Acute Coronary Syndrome (ALLEPRE)

Italy2,060 participantsStarted 2012-10

Plain-language summary

The purpose of the ALLEPRE trial is to compare the benefit offered by a structured, intensive and fully nurse-led intensive secondary prevention intervention programme with that offered by standard of care in a high-risk population of patients admitted to hospital because of an ACS.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Eligible patients aged \>18 years with an ACS (unstable angina, non- ST-segment elevation myocardial infarction \[MI\], or ST-segment elevation MI \[International Classification of Diseases, Ninth Revision, Clinical Modification codes 41071, 41001, 41011, 41021, 41031, 41041, 41051,41061, 41081, and 41091\]) who are admitted to the Cardiological Divisions of the 6 participating centers in Emilia-Romagna (Italy) are considered for enrolment for up to 20 days after the index event and before being discharged. Exclusion Criteria: Once it has been verified that the patients are capable of participating in a prospective study, the only exclusion criterion is a life expectancy of b12 months because of a severe noncardiac disease

What they're measuring

The difference in the degree of adherence to the goals concerning risk factors, lifestyle modifications and pharmacological therapy.

Timeframe: 24 months

The difference in the degree of adherence to the goals concerning risk factors, lifestyle modifications and pharmacological therapy.

Timeframe: 24 months

The difference in the degree of adherence to the goals concerning risk factors, lifestyle modifications and pharmacological therapy.

Timeframe: 24 months

The difference in the degree of adherence to the goals concerning risk factors, lifestyle modifications and pharmacological therapy.

Timeframe: 24 months

The difference in the degree of adherence to the goals concerning risk factors, lifestyle modifications and pharmacological therapy.

Timeframe: 24 months

The difference in the degree of adherence to the goals concerning risk factors, lifestyle modifications and pharmacological therapy.

Timeframe: 24 months

The difference in the degree of adherence to the goals concerning risk factors, lifestyle modifications and pharmacological therapy.

Trial details

NCT IDNCT02522182

SponsorAzienda Ospedaliero-Universitaria di Parma

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-01-31

View on ClinicalTrials.gov More Acute Coronary Syndrome trials

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

The difference in the degree of adherence to the goals concerning risk factors, lifestyle modifications and pharmacological therapy.

Timeframe: 24 months

The difference in the degree of adherence to the goals concerning risk factors, lifestyle modifications and pharmacological therapy.

Timeframe: 24 months

The difference in the degree of adherence to the goals concerning risk factors, lifestyle modifications and pharmacological therapy.

Timeframe: 24 months

The difference in the degree of adherence to the goals concerning risk factors, lifestyle modifications and pharmacological therapy.

Timeframe: 24 months

The difference in the degree of adherence to the goals concerning risk factors, lifestyle modifications and pharmacological therapy.

Timeframe: 24 months

The difference in the degree of adherence to the goals concerning risk factors, lifestyle modifications and pharmacological therapy.

Timeframe: 24 months

The difference in the degree of adherence to the goals concerning risk factors, lifestyle modifications and pharmacological therapy.